Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
نویسندگان
چکیده
c The ADA/EASD statement lists regular and NPH insulins before the longand rapid-acting insulin analogs (Table 1 in ref. [2]), and does not indicate a preference for insulin analogs despite greater nocturnal hypoglycemia with NPH and reduced postprandial fluctuation with the rapid-acting analogs. AACE/ACE indicates strong preferences for the insulin analogs in view of their reduced risk of hypoglycemia, improved pharmacodynamics, and greater consistency of effect.
منابع مشابه
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. In Table 1 " Properties of currently available glucose-lowering agents that may guide treatment choice in individual patients with type 2 diabetes mellitus " vildagliptin was incorrectly assigned footnote " a " (Limited use in the U.S./Europe) instead of footnote " b " (Not licensed in the U.S.). The online version ref...
متن کاملManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
In 2012, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a position statement on the management of hyperglycemia in patients with type 2 diabetes (1,2). This was needed because of an increasing array of antihyperglycemic drugs and growing uncertainty regarding their proper selection and sequence. Because of a paucity of comparative...
متن کاملComment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
Management of hyperglycemia in type 2 diabetes is certainly one of the most debated fields in medicine (1). Although poor possibilities in drug choice for years maintained the discussion only on what glucose target should be reached, the recent introduction of new drugs playing on different mechanisms of action compelled the debate on what drug should be chosen. Unfortunately,most drugs share s...
متن کاملResponse to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
We read the comments of Rodbard and Jellinger (1) with interest, but we feel that perhaps the very problem that the position statement of the American Diabetes Association and the European Association for the Study of Diabetes (2) was trying to circumvent comes across strongly in their communication.We have been cautious of certainty on the basis of the variety of clinical situations, the heter...
متن کاملManagement of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
The pharmacological therapy of type 2 diabetes has become increasingly complex and the goals are now more diverse and, in general, more stringent. The glycaemic target (glycated haemoglobin or HbA1c) and the medications to be prescribed to reach it should be selected according to the individual characteristics of the patient and, if possible, in agreement with him/her. The most relevant criteri...
متن کامل